PHILADELPHIA – The majority of patients with metastatic colorectal cancer whose cancer did not progress during initial treatment with...
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced that Pfizer Inc. has chosen to donate the...
SAN ANTONIO – Women 50 or older who de-escalated to less-frequent mammography three years after curative surgery for early-stage...
MRI and a DCIS gene profile were used to stratify patients for treatment SAN ANTONIO – Patients with low-risk...
SAN ANTONIO – Comprehensive profiling of fusion RNAs present in a large cohort of metastatic breast tumors revealed unique...
Study examined pregnancy and cancer outcomes among patients who paused endocrine therapy to conceive SAN ANTONIO – Using fertility...
Treatment for metastatic disease may last indefinitely, amplifying the need for effective interventions SAN ANTONIO – Among patients with...
Results are from a five-year follow-up; long-term study is needed SAN ANTONIO – Almost all postmenopausal patients aged 50-69...
Treatment de-escalation may be an option for patients whose lymph nodes become cancer free after neoadjuvant treatment SAN ANTONIO...
SAN ANTONIO – A combination of two HER2-targeted drugs, tucatinib (Tukysa) and trastuzumab emtansine (Kadcyla, T-DM1), extended progression-free survival...